Avanos Medical Inc. (AVNS)
Avanos Medical Statistics
Share Statistics
Avanos Medical has 46M shares outstanding. The number of shares has increased by 0.22% in one year.
| Shares Outstanding | 46M |
| Shares Change (YoY) | 0.22% |
| Shares Change (QoQ) | 0.1% |
| Owned by Institutions (%) | 93.76% |
| Shares Floating | 44.87M |
| Failed to Deliver (FTD) Shares | 8 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 666.87K, so 1.45% of the outstanding shares have been sold short.
| Short Interest | 666.87K |
| Short % of Shares Out | 1.45% |
| Short % of Float | 1.49% |
| Short Ratio (days to cover) | 1.14 |
Valuation Ratios
The PE ratio is -1.87 and the forward PE ratio is 10.11. Avanos Medical's PEG ratio is 0.
| PE Ratio | -1.87 |
| Forward PE | 10.11 |
| PS Ratio | 1.06 |
| Forward PS | 0.9 |
| PB Ratio | 0.88 |
| P/FCF Ratio | 8.83 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Avanos Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.21.
| Current Ratio | 2.37 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | -0.49 |
| Debt / FCF | 2.05 |
| Interest Coverage | -32.48 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $308.85K |
| Profits Per Employee | $-176.07K |
| Employee Count | 2,227 |
| Asset Turnover | 0.6 |
| Inventory Turnover | 2.21 |
Taxes
| Income Tax | -17M |
| Effective Tax Rate | 4.22% |
Stock Price Statistics
The stock price has increased by -31.18% in the last 52 weeks. The beta is 1.15, so Avanos Medical's price volatility has been higher than the market average.
| Beta | 1.15 |
| 52-Week Price Change | -31.18% |
| 50-Day Moving Average | 15.46 |
| 200-Day Moving Average | 19.39 |
| Relative Strength Index (RSI) | 29.56 |
| Average Volume (20 Days) | 550.62K |
Income Statement
In the last 12 months, Avanos Medical had revenue of 687.8M and earned -392.1M in profits. Earnings per share was -8.52.
| Revenue | 687.8M |
| Gross Profit | 381.3M |
| Operating Income | -396.2M |
| Net Income | -392.1M |
| EBITDA | -345.6M |
| EBIT | -391.1M |
| Earnings Per Share (EPS) | -8.52 |
Balance Sheet
The company has 107.7M in cash and 170.2M in debt, giving a net cash position of -62.5M.
| Cash & Cash Equivalents | 107.7M |
| Total Debt | 170.2M |
| Net Cash | -62.5M |
| Retained Earnings | -707M |
| Total Assets | 1.15B |
| Working Capital | 227.5M |
Cash Flow
In the last 12 months, operating cash flow was 100.7M and capital expenditures -17.8M, giving a free cash flow of 82.9M.
| Operating Cash Flow | 100.7M |
| Capital Expenditures | -17.8M |
| Free Cash Flow | 82.9M |
| FCF Per Share | 1.8 |
Margins
Gross margin is 55.44%, with operating and profit margins of -57.6% and -57.01%.
| Gross Margin | 55.44% |
| Operating Margin | -57.6% |
| Pretax Margin | -58.64% |
| Profit Margin | -57.01% |
| EBITDA Margin | -50.25% |
| EBIT Margin | -57.6% |
| FCF Margin | 12.05% |
Dividends & Yields
AVNS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for AVNS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 0.96 |
| Piotroski F-Score | 6 |